[CAR-T细胞治疗治疗结直肠癌的进展]
Zijian Chao1, Wenli Liu1, Yu Liu1
1College of Life Sciences and Health, Wuhan University of Science and Technology, Wuhan 430065, Hubei, China.
概括
化学抗原受体T (CAR-T) 细胞疗法对结直肠癌 (CRC) 治疗有前途,向特定标记物. 然而,像瘤特异性和瘤微环境这样的挑战需要解决,以便在CRC中有效的CAR-T治疗.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 细胞疗法细胞疗法
背景情况:
- 结肠直肠癌 (CRC) 是全球癌症相关死亡的主要原因.
- 化学抗原受体T (CAR-T) 细胞疗法已在血液癌症中取得成功,并正在研究像CRC这样的固体瘤.
研究的目的:
- 审查在结直肠癌中CAR-T细胞治疗的有希望的标.
- 突出CRC的CAR-T治疗临床和临床前研究的进展和挑战.
主要方法:
- 临床试验和临床前研究对治疗CRC的CAR-T细胞疗法的综述.
- 已识别的CAR-T标的摘要,如癌胚抗原 (CEA) 和自然杀手组2的成员D连接体 (NKG2DL).
主要成果:
- 针对CEA和NKG2DL的CAR-T疗法在CRC的临床试验中显示出有希望的结果.
- 仍然存在重大挑战,包括识别瘤特异性抗原,管理细胞因子释放综合征,克服瘤微环境,改善CAR-T细胞透.
结论:
- 卡尔-T细胞疗法具有结直肠癌治疗的潜力,目前正在研究点并克服治疗障碍.
- 需要进一步的见解来推进CAR-T细胞疗法,以便在CRC中有效的临床应用.
相关概念视频
Tumor Immunotherapy
515
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
515
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K

![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)
